Abiopharma

🔍 Burth Jonathan (Executive)

Company: Vita Coco Company, Inc. (COCO)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 20,000 shares of Common Stock at $10.178 per share (Direct)
  Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 77,910.00 | transaction_form_type: 4
• Sold 20,000 shares of Common Stock at $65.0 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 77,910.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 20,000 shares of Common Stock at $10.178 per share (Direct)
  Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 97,910.00 | transaction_form_type: 4
• Sold 20,000 shares of Common Stock at $62.5 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 57,910.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 20,000 shares of Common Stock at $10.178 per share (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 77,910.00 | transaction_form_type: 4
• Sold 20,000 shares of Common Stock at $67.5 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 57,910.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 20,000 shares of Non-Qualified Stock Option (Right to Buy) at $10.178 per share (Derivative)
  Date: 2026-04-29 | Code: M | Expires: 2030-02-10 | equity_swap_involved: 0 | shares_owned_after: 113,575.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 20,000 shares of Non-Qualified Stock Option (Right to Buy) at $10.178 per share (Derivative)
  Date: 2026-04-29 | Code: M | Expires: 2030-02-10 | equity_swap_involved: 0 | shares_owned_after: 93,575.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 20,000 shares of Non-Qualified Stock Option (Right to Buy) at $10.178 per share (Derivative)
  Date: 2026-04-30 | Code: M | Expires: 2030-02-10 | equity_swap_involved: 0 | shares_owned_after: 73,575.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 40,950 shares of Non-Qualified Stock Option (Right to Buy) at $10.178 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2030-02-10 | shares_owned_after: 40,950.00 | Footnotes: F3
• Holds 34,125 shares of Non-Qualified Stock Option (Right to Buy) at $10.178 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2031-01-11 | shares_owned_after: 34,125.00 | Footnotes: F2
• Holds 58,043 shares of Non-Qualified Stock Option (Right to Buy) at $15.0 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2031-10-21 | shares_owned_after: 58,043.00 | Footnotes: F4
• Holds 42,980 shares of Non-Qualified Stock Option (Right to Buy) at $15.36 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2032-08-15 | shares_owned_after: 42,980.00 | Footnotes: F5
• Holds 14,025 shares of Non-Qualified Stock Option (Right to Buy) at $16.91 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2033-03-10 | shares_owned_after: 14,025.00 | Footnotes: F6
• Holds 14,205 shares of Non-Qualified Stock Option (Right to Buy) at $16.91 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2033-03-10 | shares_owned_after: 14,205.00 | Footnotes: F7
• Holds 8,746 shares of Non-Qualified Stock Option (Right to Buy) at $26.18 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2034-03-04 | shares_owned_after: 8,746.00 | Footnotes: F8
• Holds 13,218 shares of Non-Qualified Stock Option (Right to Buy) at $33.36 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2035-03-04 | shares_owned_after: 13,218.00 | Footnotes: F9

Footnotes:

• F1: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
• F2: The stock option is fully vested and currently exercisable.
• F3: The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.
• F4: The stock option vests in four equal annual installments beginning on November 27, 2022.
• F5: The stock option vests in three equal annual installments beginning on August 15, 2025.
• F6: The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
• F7: The stock option vests in four equal annual installments beginning on March 10, 2024.
• F8: The stock option vests in four equal annual installments beginning on March 4, 2025.
• F9: The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.